Surface treatments reach two millimetres. Near-infrared reaches inside the joint — the depth that changes outcomes

The physics of tissue penetration: why wavelength determines depth

Electromagnetic radiation interacts with biological tissue through absorption and scattering. Different wavelengths are absorbed by different chromophores — the molecules that capture light energy. Haemoglobin, melanin and water absorb visible red light efficiently, which limits its penetration to approximately 5–10 millimetres of tissue before the energy is fully absorbed. Near-infrared wavelengths (750–1000nm) pass through these superficial chromophores with less absorption, penetrating 20–50 millimetres into tissue before the cumulative absorption reduces the remaining irradiance below therapeutic levels. This is not a marginal difference: 850nm light reaches the cartilage of a knee joint, the facet capsule of a lumbar vertebra, and the tendon-bone insertion of the Achilles tendon. 660nm light does not.

Joint pain at depth: what near-infrared reaches that nothing else does non-invasively

The synovial membrane lining of major joints — the tissue responsible for producing the inflammatory mediators that cause joint pain and swelling in osteoarthritis and rheumatoid arthritis — sits 15–25 millimetres below the skin surface in most major joints. Topical anti-inflammatory gels do not penetrate to this depth. Oral NSAIDs reach the synovial membrane through systemic circulation but carry the full systemic side-effect profile. Near-infrared photobiomodulation represents one of the few non-invasive, non-pharmacological interventions that can deliver an anti-inflammatory signal directly to the synovial membrane from the skin surface — modulating IL-1β, IL-6 and TNF-α production in the inflamed synovium through direct photon absorption in the tissue.

The combination advantage: red plus near-infrared in a single device

Combination belts that deliver both 660nm red and 850nm near-infrared wavelengths simultaneously address the complete depth spectrum from skin surface to joint interior in a single session. The red wavelength treats the periarticular skin tissue and superficial musculature, improving local circulation and reducing surface-level inflammation. The near-infrared wavelength simultaneously treats the deeper joint structures, modulating inflammatory signalling in the synovium and subchondral bone. Using both wavelengths in the same session is more efficient than alternating between single-wavelength devices and produces superior outcomes to either wavelength used alone — which is why every professional clinical photobiomodulation system has always used dual-wavelength emission.

Muscle belly treatment: near-infrared for delayed-onset soreness and chronic tension

The deep portion of large muscle groups — the centre of the gastrocnemius belly, the deep fibres of the gluteus maximus, the thoracic erector spinae — sit 20–40 millimetres below the skin surface, beyond the penetration depth of visible red light. Near-infrared at 850nm reaches these deep fibres and produces the same mitochondrial activation that occurs at more superficial depths: increased ATP synthesis, modulated inflammatory cytokine production and enhanced cellular repair. For delayed-onset muscle soreness, where the inflammatory response to exercise-induced micro-damage is occurring throughout the full depth of the muscle belly, near-infrared treatment of the entire muscle cross-section produces faster recovery than surface-limited red light treatment of the same area.

Belt dosing: calculating near-infrared dose at depth

The irradiance at depth is not the same as the irradiance at the skin surface — the tissue itself attenuates the light through absorption and scattering, reducing the effective dose with increasing distance from the emitter. For a belt device at skin contact, the irradiance at the emitter surface is the starting point; at 20mm depth (the approximate depth of a major joint capsule), the residual irradiance is typically 10–20% of the surface value, depending on tissue composition. This means that achieving a therapeutic dose (10 J/cm²) at joint depth requires significantly longer session times or higher surface irradiance than achieving the same dose at skin surface. The practical recommendation for joint-depth treatment with a contact belt is 20–25 minutes per session rather than the 10–15 minutes sufficient for superficial applications.